Jean Sauvain

University of Rochester Cancer CenterRochester, New York - 14642 (585-273-3150) |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS3
- SINCE2008

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
July 2008 - June 2013
Neoplasms
Urinary Bladder Neoplasms
Carcinoma
Carcinoma, Transitional Cell
Pralatrexate Injection
Vitamin B12
Folic Acid



